{"id":"W2955283109","doi":"10.1158/1078-0432.ccr-18-3944","title":"Nivolumab in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: Efficacy and Safety in CheckMate 141 by Prior Cetuximab Use","year":2019,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":160,"is_retracted":false,"has_abstract":true,"ca_institutions":"Institute of Cancer Research","funders":"National Institutes of Health; Ono Pharmaceutical; National Cancer Institute; National Institute for Health and Care Research; Bristol-Myers Squibb","keywords":"Cetuximab; Nivolumab; Medicine; Head and neck; Head and neck squamous-cell carcinoma; Oncology; Basal cell; Internal medicine; Head and neck cancer; Cancer; Surgery; Immunotherapy; Colorectal cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001517526,0.0003093533,0.0008121023,0.0001761198,0.0002193977,0.0004877379,0.0003479427,0.0005654632,0.00120992],"category_scores_gemma":[0.00134501,0.0001939618,0.001074868,0.0002154242,0.000334139,0.0004067113,0.0002627058,0.0009039418,0.0001443145],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009186705,"about_ca_system_score_gemma":0.0008239158,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009650279,"about_ca_topic_score_gemma":0.00336305,"domain_scores_codex":[0.9995137,0.0002005983,0.00003624454,0.00009248027,0.00009424045,0.00006269272],"domain_scores_gemma":[0.9993973,0.0002012377,0.0001774244,0.00004414404,0.00003587865,0.000144103],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5479373,0.01302268,0.1473465,0.001090762,0.002483971,0.000264393,0.0002500279,0.003605007,0.03616647,0.0002165524,0.00167684,0.2459395],"study_design_scores_gemma":[0.1000054,0.3116669,0.5641571,0.000184399,0.002943826,0.0007845945,0.0001269874,0.005243576,0.01024851,0.0002741415,0.00430351,0.00006110238],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9976475,0.001577163,0.00005587084,0.00007618664,0.00001791667,0.00008992969,0.00007436205,0.000007233034,0.0004538001],"genre_scores_gemma":[0.999057,0.0003324982,0.00008289109,0.0001382518,0.00002989985,0.00004804827,0.0001553011,0.00000146946,0.0001547532],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001517526,"threshold_uncertainty_score":0.008025527,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09167109629543041,"score_gpt":0.4198247893083826,"score_spread":0.3281536930129522,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}